Associate Director – US & WW Forecasting, Commercialization Analytics- Cardiovascular at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

BA/BS in relevant functional discipline required; Advanced degree preferred
Minimum of 5 years relevant experience within pharmaceutical industry and/or consulting preferred
Experience in forecasting, forecast

Responsibilities

Independently engages as a business partner to the ICV Commercial team for ongoing commercialization
Earns status as a trusted advisor, embedding customer & market insights and analytics into business decision making
Partners with key stakeholders within the Commercial ICV Team to support strategic and tactical commercial decisions through: Forecasting Scenarios, Key Assumption Drivers, Performance Tracking, and Secondary Data Analytics
Executes business analysis to improve value to our patients through deepened market understanding, subject matter expertise, and practical application
Delivers integrated US & WW short-term forecasts and long-term plans across various countries, with fully integrated market research and secondary data analytics assumptions to establish financial expectations
Supports culture of fact-based decision making through application of best-in-class, innovative, and appropriate methodologies to address key business questions
Effectively collaborates with a broad set of cross functional counterparts (including Brand Leadership, Sales Operations, Medical, and Finance) to achieve organizational objectives
Proactively manages flow of planned and ad hoc analytics requests, ensuring consistent quality and timeliness in delivery to business stakeholders
Develops seamless, collaborative, cross-functional approaches to problem solving and holistic cross-customer analysis
Develops and maintains a deep understanding of US & WW ICV brand priorities
Understands, demonstrates, and drives adherence to all BMS operating policies

Skills

Forecasting

Commercialization Analytics

Market Research

Secondary Data Analytics

Immunology

Cardiovascular

Commercial Strategy

Performance Analytics

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free